Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Study Details
Study Description
Brief Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy after surgery may kill any remaining tumor cells following surgery. It is not yet known which chemotherapy and radiation therapy regimen is more effective in treating stomach or esophageal cancer.
PURPOSE: Randomized phase III trial to compare two different chemotherapy and radiation therapy regimens in treating patients who have undergone surgery for stomach or esophageal cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
OBJECTIVES:
-
Compare overall survival in patients with resected gastric adenocarcinoma treated with epirubicin, cisplatin, and infusional fluorouracil (5-FU) vs 5-FU bolus and leucovorin calcium before and after 5-FU plus radiotherapy.
-
Compare disease-free survival and local and distant recurrence rates in these patients treated with these regimens.
-
Correlate the expression of putative prognostic markers (including TS, ERCC-1, MSI, E-cadherin, EGFR, p27, COX-2, and c-erbB-2) with overall survival of patients treated with these regimens.
-
Correlate specific germline polymorphisms related to chemotherapy metabolism and resistance (including UGT2B7 [epirubicin], GST [cisplatin], ERCCI [cisplatin], XRCC1 [cisplatin], TS [5-FU], DPD [5-FU], and EGFR polymorphisms) with treatment-related toxicity and overall survival of these patients.
-
Correlate serum levels of insulin-like growth factor-1 (IGF-1), IGF-2, and IGF-binding protein 3 with overall survival of patients treated with these regimens.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to depth of tumor penetration (T1 or T2 vs T3 vs T4), lymph node involvement (0 vs 1-3), and extent of lymphadenectomy (D1 or D2 vs D0 or unknown). Patients are randomized to 1 of 2 treatment arms.
-
Arm I: Patients receive leucovorin calcium IV and fluorouracil (5-FU) IV on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days between course 2 and 3.
-
Arm II: Patients receive epirubicin IV over 3-15 minutes and cisplatin IV over 1 hour on day 1 and 5-FU IV continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses.
Patients are followed every 3 months for 2 years, every 4 months for 2 years, and then annually for 3 years.
PROJECTED ACCRUAL: A total of 824 patients will be accrued for this study.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Arm I Patients receive leucovorin calcium IV and fluorouracil (5-FU) IV on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 to 6 weeks. Patients rest for 28-35 days between course 2 and 3. |
Drug: fluorouracil
Given IV
Drug: leucovorin calcium
Given IV
Radiation: radiation therapy
Given 5 days a week for 5 weeks
|
Experimental: Arm II Patients receive epirubicin IV over 3-15 minutes and cisplatin IV over 1 hour on day 1 and 5-FU IV continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses. |
Drug: cisplatin
Given IV
Drug: epirubicin hydrochloride
Given IV
Drug: fluorouracil
Given IV
Radiation: radiation therapy
Given 5 days a week for 5 weeks
|
Outcome Measures
Primary Outcome Measures
- Overall Survival [From study enrollment until death from any cause; up to 3 years]
Overall survival is defined as the time from study enrollment to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier.
Secondary Outcome Measures
- Disease Free Survival [From the date of study enrollment until death or documented second primary tumor, or cancer recurrence; up to 4 years]
Disease free survival is defined as the time from the date of study enrollment to death or documented second primary tumor, or cancer recurrence.The distribution of disease free survival time will be estimated using the method of Kaplan-Meier.
Eligibility Criteria
Criteria
- Required Tumor Parameters
1.1 Patients must have histologically diagnosed adenocarcinoma of the stomach or gastroesophageal junction. Adenocarcinomas of the esophagus that are not involving the gastroesophageal junction are not eligible.
1.2 Patients must have had en bloc resection of all known tumor. The surgical resection must have been done with a curative intent.
1.3 Patients must have tumor extension beyond muscularis propria and/or nodal involvement without evidence of M1 disease.
-
Patients can have stages IB if there is evidence of either node-positive (N1) disease or tumor extension beyond the muscularis propria (i.e., T1, N1, M0 patients are eligible but patients with T2, N0, M0 are allowed only if there is extension beyond the muscularis propria).
-
Patients can have stages II, IIIA, IIIB or stage IV with M0 (i.e., T4N2M0).
-
Stages 0, IA, or any stage with M1 are not allowed. (see Appendix I for TNM staging guide).
1.4 Patients with known unresected cancer, recurrent cancer, microscopic evidence of tumor at the distal or proximal line of stomach resection, noncontiguous resection of tumor, or M1 (metastatic) disease are ineligible.
- Prior Therapy
2.1 No prior therapy (except hormonal or biologic) for other malignancies is allowed except for adequately treated basal cell or squamous cell skin cancer, noninvasive carcinoma in situ which has been fully resected, or other cancer for which the patient has been disease free for five years.
2.2 Patients who have had any previous chemotherapy or radiotherapy are ineligible.
- Patient Characteristics
3.1 Patients must have an ECOG (CTC) performance status of 0, 1 or 2.
3.2 Patients are required to have an adequate total caloric intake to allow them to maintain their post-surgical body weight. Patients must have documentation of stable weight (or less than 2 pounds weight loss) for at least one week prior to registration.
3.3 All patients must be evaluated by a radiation oncologist (prior to enrollment) to ensure that the patient is an appropriate candidate for radiation therapy.
3.4 Patients may not have unilateral renal function (only one functioning kidney) as determined by CT scan with contrast, urogram, renal scan, or other study.
3.5 Pregnant or lactating women may not participate. Men and women of reproductive potential may not participate unless they have agreed to use an effective contraceptive method or practice abstinence while in this study.
-
The effects of therapeutic radiotherapy are known to be teratogenic.
-
The effects of Epirubicin, Cisplatin, and 5-FU on a developing human fetus at the recommended therapeutic dose are less well known.
-
For this reason and because DNA alkylating agents are known to be teratogenic, women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control) prior to study entry and for the duration of study participation.
-
Should a woman become pregnant or suspect she is pregnant while participating on this study, she should inform her treating physician immediately. Because the risk of toxicity in nursing infants secondary to Epirubicin, Cisplatin, and 5-FU treatment of the mother is unknown but may be harmful, breastfeeding should be discontinued.
3.6 Patients with any of the following cardiac conditions are ineligible:
-
Uncontrolled high blood pressure
-
Unstable angina
-
Symptomatic congestive heart failure
-
Myocardial infarction < 6 months prior to registration
-
Serious uncontrolled cardiac arrhythmia
-
New York Heart Association classification III or IV.
3.7 No uncontrolled serious medical or psychiatric illness which would prevent compliance with treatment or adequate informed consent.
3.8 Patients with active infectious process are ineligible.
3.9 Patients with grade 2 or greater peripheral neuropathy at baseline are ineligible.
- Required Initial Laboratory Values:
-
Granulocytes ≥ 1,500/μl
-
Platelet count ≥ 100,000/μl
-
Creatinine ≤ 1.5 mg/dl
-
Bilirubin ≤ 2.0 mg/dl
-
AST ≤ 3x upper limits of normal
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Regional Medical Center | Anniston | Alabama | United States | 36202 |
2 | Providence Cancer Center at Providence Hospital | Mobile | Alabama | United States | 36608 |
3 | Mayo Clinic Scottsdale | Scottsdale | Arizona | United States | 85259-5499 |
4 | Arizona Cancer Center at University of Arizona Health Sciences Center | Tucson | Arizona | United States | 85724-5024 |
5 | Hembree Mercy Cancer Center at St. Edward Mercy Medical Center | Fort Smith | Arkansas | United States | 72903 |
6 | Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center | Jonesboro | Arkansas | United States | 72401-9320 |
7 | Arkansas Cancer Research Center at University of Arkansas for Medical Sciences | Little Rock | Arkansas | United States | 72205 |
8 | Kaiser Permanente - Deer Valley | Antioch | California | United States | 94531 |
9 | Providence Saint Joseph Medical Center - Burbank | Burbank | California | United States | 91505 |
10 | East Bay Radiation Oncology Center | Castro Valley | California | United States | 94546 |
11 | Eden Medical Center | Castro Valley | California | United States | 94546 |
12 | Valley Medical Oncology Consultants - Castro Valley | Castro Valley | California | United States | 94546 |
13 | City of Hope Comprehensive Cancer Center | Duarte | California | United States | 91010-3000 |
14 | Kaiser Permanente - Fremont | Fremont | California | United States | 94538 |
15 | Valley Medical Oncology | Fremont | California | United States | 94538 |
16 | Glendale Memorial Hospital Comprehensive Cancer Center | Glendale | California | United States | 91204 |
17 | Kaiser Permanente Medical Center - Hayward | Hayward | California | United States | 94545 |
18 | Rebecca and John Moores UCSD Cancer Center | La Jolla | California | United States | 92093-0658 |
19 | Contra Costa Regional Medical Center | Martinez | California | United States | 94553-3156 |
20 | Memorial Medical Center | Modesto | California | United States | 95355 |
21 | Community Hospital of the Monterey Peninsula Comprehensive Cancer Center | Monterey | California | United States | 93940 |
22 | Camino Medical Group - Treatment Center | Mountain View | California | United States | 94040 |
23 | El Camino Hospital Cancer Center | Mountain View | California | United States | 94040 |
24 | Highland General Hospital | Oakland | California | United States | 94602 |
25 | Alta Bates Summit Medical Center - Summit Campus | Oakland | California | United States | 94609 |
26 | Bay Area Breast Surgeons, Incorporated | Oakland | California | United States | 94609 |
27 | CCOP - Bay Area Tumor Institute | Oakland | California | United States | 94609 |
28 | Larry G Strieff MD Medical Corporation | Oakland | California | United States | 94609 |
29 | Tom K Lee, Incorporated | Oakland | California | United States | 94609 |
30 | Kaiser Permanente Medical Center - Oakland | Oakland | California | United States | 94611 |
31 | Valley Care Medical Center | Pleasanton | California | United States | 94588 |
32 | Valley Medical Oncology Consultants - Pleasanton | Pleasanton | California | United States | 94588 |
33 | Kaiser Permanente Medical Center - Redwood City | Redwood City | California | United States | 94063 |
34 | Kaiser Permanente Medical Center - Richmond | Richmond | California | United States | 94801 |
35 | Kaiser Permanente Medical Center - Roseville | Roseville | California | United States | 95661 |
36 | South Sacramento Kaiser-Permanente Medical Center | Sacramento | California | United States | 95823 |
37 | Kaiser Permanente Medical Center - Sacramento | Sacramento | California | United States | 95825 |
38 | San Francisco General Hospital Medical Center | San Francisco | California | United States | 94110 |
39 | Kaiser Permanente Medical Center - San Francisco Geary Campus | San Francisco | California | United States | 94115 |
40 | Kaiser Permanente Medical Center - Santa Teresa | San Jose | California | United States | 95119 |
41 | Doctors Medical Center - San Pablo Campus | San Pablo | California | United States | 94806 |
42 | Kaiser Foundation Hospital - San Rafael | San Rafael | California | United States | 94903 |
43 | Kaiser Permanente Medical Center - Santa Clara Kiely Campus | Santa Clara | California | United States | 95051 |
44 | Kaiser Permanente Medical Center - Santa Rosa | Santa Rosa | California | United States | 95403 |
45 | Kaiser Permanente Medical Center - South San Francisco | South San Francisco | California | United States | 94080 |
46 | Kaiser Permanente Medical Facility - Stockton | Stockton | California | United States | 95210 |
47 | Kaiser Permanente Medical Center - Vallejo | Vallejo | California | United States | 94589 |
48 | Kaiser Permanente Medical Center - Walnut Creek | Walnut Creek | California | United States | 94596 |
49 | Aurora Presbyterian Hospital | Aurora | Colorado | United States | 80012 |
50 | Boulder Community Hospital | Boulder | Colorado | United States | 80301-9019 |
51 | Memorial Hospital Cancer Center - Colorado Springs | Colorado Springs | Colorado | United States | 80909 |
52 | Penrose Cancer Center at Penrose Hospital | Colorado Springs | Colorado | United States | 80933 |
53 | St. Anthony Central Hospital | Denver | Colorado | United States | 80204 |
54 | Porter Adventist Hospital | Denver | Colorado | United States | 80210 |
55 | Presbyterian - St. Luke's Medical Center | Denver | Colorado | United States | 80218 |
56 | St. Joseph Hospital | Denver | Colorado | United States | 80218 |
57 | Rose Medical Center | Denver | Colorado | United States | 80220 |
58 | CCOP - Colorado Cancer Research Program | Denver | Colorado | United States | 80224-2522 |
59 | Swedish Medical Center | Englewood | Colorado | United States | 80110 |
60 | St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center | Grand Junction | Colorado | United States | 81502 |
61 | North Colorado Medical Center | Greeley | Colorado | United States | 80631 |
62 | Sky Ridge Medical Center | Lone Tree | Colorado | United States | 80124 |
63 | Hope Cancer Care Center at Longmont United Hospital | Longmont | Colorado | United States | 80501 |
64 | McKee Medical Center | Loveland | Colorado | United States | 80539 |
65 | St. Mary - Corwin Regional Medical Center | Pueblo | Colorado | United States | 81004 |
66 | North Suburban Medical Center | Thornton | Colorado | United States | 80229 |
67 | Exempla Lutheran Medical Center | Wheat Ridge | Colorado | United States | 80033 |
68 | Praxair Cancer Center at Danbury Hospital | Danbury | Connecticut | United States | 06810 |
69 | Helen and Harry Gray Cancer Center at Hartford Hospital | Hartford | Connecticut | United States | 06102-5037 |
70 | Tunnell Cancer Center at Beebe Medical Center | Lewes | Delaware | United States | 19958 |
71 | CCOP - Christiana Care Health Services | Newark | Delaware | United States | 19713 |
72 | Lombardi Comprehensive Cancer Center at Georgetown University Medical Center | Washington | District of Columbia | United States | 20007 |
73 | Walter Reed Army Medical Center | Washington | District of Columbia | United States | 20307-5001 |
74 | Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus | Boca Raton | Florida | United States | 33486 |
75 | Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital | Fort Lauderdale | Florida | United States | 33308 |
76 | Broward General Medical Center Cancer Center | Fort Lauderdale | Florida | United States | 33316 |
77 | Memorial Cancer Institute at Memorial Regional Hospital | Hollywood | Florida | United States | 33021 |
78 | Baptist Cancer Institute - Jacksonville | Jacksonville | Florida | United States | 32207 |
79 | Ella Milbank Foshay Cancer Center at Jupiter Medical Center | Jupiter | Florida | United States | 33458 |
80 | Center for Cancer Care and Research at Watson Clinic, LLP | Lakeland | Florida | United States | 33805 |
81 | CCOP - Mount Sinai Medical Center | Miami Beach | Florida | United States | 33140 |
82 | Sacred Heart Cancer Center at Sacred Heart Hospital | Pensacola | Florida | United States | 32504 |
83 | West Florida Cancer Institute at West Florida Hospital - Pensacola | Pensacola | Florida | United States | 32514 |
84 | Cleveland Clinic Florida - Weston | Weston | Florida | United States | 33331 |
85 | Phoebe Cancer Center at Phoebe Putney Memorial Hospital | Albany | Georgia | United States | 31701 |
86 | Winship Cancer Institute of Emory University | Atlanta | Georgia | United States | 30322 |
87 | Veterans Affairs Medical Center - Atlanta (Decatur) | Decatur | Georgia | United States | 30033 |
88 | Medical Center of Central Georgia | Macon | Georgia | United States | 31208 |
89 | Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center | Savannah | Georgia | United States | 31403-3089 |
90 | Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler | Savannah | Georgia | United States | 31405 |
91 | Mountain States Tumor Institute at St. Luke's Regional Medical Center | Boise | Idaho | United States | 83712 |
92 | Rush-Copley Cancer Care Center | Aurora | Illinois | United States | 60504 |
93 | Hematology Oncology Associates of Illinois - Berwyn | Berwyn | Illinois | United States | 60402 |
94 | Robert H. Lurie Comprehensive Cancer Center at Northwestern University | Chicago | Illinois | United States | 60611-3013 |
95 | Hematology and Oncology Associates | Chicago | Illinois | United States | 60611 |
96 | University of Illinois Cancer Center | Chicago | Illinois | United States | 60612-7243 |
97 | Veterans Affairs Medical Center - Chicago Westside Hospital | Chicago | Illinois | United States | 60612 |
98 | Resurrection Medical Center | Chicago | Illinois | United States | 60631 |
99 | University of Chicago Cancer Research Center | Chicago | Illinois | United States | 60637-1470 |
100 | Creticos Cancer Center at Advocate Illinois Masonic Medical Center | Chicago | Illinois | United States | 60657 |
101 | Decatur Memorial Hospital Cancer Care Institute | Decatur | Illinois | United States | 62526 |
102 | St. Anthony's Memorial Hospital | Effingham | Illinois | United States | 62401 |
103 | Elmhurst Memorial Hospital | Elmhurst | Illinois | United States | 60126 |
104 | Ingalls Cancer Care Center at Ingalls Memorial Hospital | Harvey | Illinois | United States | 60426 |
105 | Veterans Affairs Medical Center - Hines | Hines | Illinois | United States | 60141 |
106 | Midwest Center for Hematology/Oncology | Joliet | Illinois | United States | 60432 |
107 | Joliet Oncology-Hematology Associates, Limited - West | Joliet | Illinois | United States | 60435 |
108 | La Grange Memorial Hospital | La Grange | Illinois | United States | 60525 |
109 | North Shore Oncology and Hematology Associates, Limited - Libertyville | Libertyville | Illinois | United States | 60048 |
110 | Cardinal Bernardin Cancer Center at Loyola University Medical Center | Maywood | Illinois | United States | 60153 |
111 | Edward Hospital Cancer Center | Naperville | Illinois | United States | 60540 |
112 | Hematology Oncology Consultants - Naperville | Naperville | Illinois | United States | 60540 |
113 | La Grange Oncology Associates - Geneva | Naperville | Illinois | United States | 60563 |
114 | Cancer Care and Hematology Specialists of Chicagoland - Niles | Niles | Illinois | United States | 60714 |
115 | Advocate Christ Medical Center | Oak Lawn | Illinois | United States | 60453-2699 |
116 | Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields | Olympia Fields | Illinois | United States | 60461 |
117 | West Suburban Center for Cancer Care | River Forest | Illinois | United States | 60305 |
118 | Swedish-American Regional Cancer Center | Rockford | Illinois | United States | 61104-2315 |
119 | Hematology Oncology Associates - Skokie | Skokie | Illinois | United States | 60076 |
120 | Regional Cancer Center at Memorial Medical Center | Springfield | Illinois | United States | 62781-0001 |
121 | Carle Cancer Center at Carle Foundation Hospital | Urbana | Illinois | United States | 61801 |
122 | CCOP - Carle Cancer Center | Urbana | Illinois | United States | 61801 |
123 | St. Francis Hospital and Health Centers - Beech Grove Campus | Beech Grove | Indiana | United States | 46107 |
124 | Elkhart General Hospital | Elkhart | Indiana | United States | 46515 |
125 | Fort Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | United States | 46845 |
126 | Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | United States | 46202-5289 |
127 | William N. Wishard Memorial Hospital | Indianapolis | Indiana | United States | 46202 |
128 | Howard Community Hospital | Kokomo | Indiana | United States | 46904 |
129 | Center for Cancer Therapy at LaPorte Hospital and Health Services | La Porte | Indiana | United States | 46350 |
130 | Saint Anthony Memorial Health Centers | Michigan City | Indiana | United States | 46360 |
131 | Cancer Center at Ball Memorial Hospital | Muncie | Indiana | United States | 47303-3499 |
132 | Medical Consultants, PC at Ball Memorial Cancer Center | Muncie | Indiana | United States | 47303 |
133 | Community Hospital | Munster | Indiana | United States | 46321 |
134 | Reid Hospital & Health Care Services | Richmond | Indiana | United States | 47374 |
135 | CCOP - Northern Indiana CR Consortium | South Bend | Indiana | United States | 46601 |
136 | Memorial Hospital of South Bend | South Bend | Indiana | United States | 46601 |
137 | Saint Joseph Regional Medical Center | South Bend | Indiana | United States | 46617 |
138 | South Bend Clinic | South Bend | Indiana | United States | 46617 |
139 | McFarland Clinic, PC | Ames | Iowa | United States | 50010 |
140 | Hematology Oncology Associates of the Quad Cities | Bettendorf | Iowa | United States | 52722 |
141 | Iowa Blood and Cancer Care | Cedar Rapids | Iowa | United States | 52402 |
142 | St. Luke's Hospital | Cedar Rapids | Iowa | United States | 52402 |
143 | Mercy Regional Cancer Center at Mercy Medical Center | Cedar Rapids | Iowa | United States | 52403 |
144 | Mercy Capitol Hospital | Des Moines | Iowa | United States | 50307 |
145 | CCOP - Iowa Oncology Research Association | Des Moines | Iowa | United States | 50309 |
146 | John Stoddard Cancer Center at Iowa Methodist Medical Center | Des Moines | Iowa | United States | 50309 |
147 | Medical Oncology and Hematology Associates at John Stoddard Cancer Center | Des Moines | Iowa | United States | 50309 |
148 | Medical Oncology and Hematology Associates at Mercy Cancer Center | Des Moines | Iowa | United States | 50314 |
149 | Mercy Cancer Center at Mercy Medical Center - Des Moines | Des Moines | Iowa | United States | 50314 |
150 | John Stoddard Cancer Center at Iowa Lutheran Hospital | Des Moines | Iowa | United States | 50316 |
151 | Holden Comprehensive Cancer Center at University of Iowa | Iowa City | Iowa | United States | 52242-1002 |
152 | McCreery Cancer Center at Ottumwa Regional | Ottumwa | Iowa | United States | 52501 |
153 | Siouxland Hematology-Oncology Associates, LLP | Sioux City | Iowa | United States | 51101 |
154 | Mercy Medical Center - Sioux City | Sioux City | Iowa | United States | 51104 |
155 | St. Luke's Regional Medical Center | Sioux City | Iowa | United States | 51104 |
156 | Cedar Valley Medical Specialists, PC - West Ridgeway Avenue | Waterloo | Iowa | United States | 50701 |
157 | Covenant Cancer Treatment Center | Waterloo | Iowa | United States | 50702 |
158 | Medical Oncology and Hematology Associates - West Des Moines | West Des Moines | Iowa | United States | 50266 |
159 | Cancer Center of Kansas, PA - Chanute | Chanute | Kansas | United States | 66720 |
160 | Cancer Center of Kansas, PA - Dodge City | Dodge City | Kansas | United States | 67801 |
161 | Cancer Center of Kansas, PA - El Dorado | El Dorado | Kansas | United States | 67042 |
162 | Cancer Center of Kansas - Fort Scott | Fort Scott | Kansas | United States | 66701 |
163 | Cancer Center of Kansas-Independence | Independence | Kansas | United States | 67301 |
164 | Cancer Center of Kansas, PA - Kingman | Kingman | Kansas | United States | 67068 |
165 | Lawrence Memorial Hospital | Lawrence | Kansas | United States | 66044 |
166 | Southwest Medical Center | Liberal | Kansas | United States | 67901 |
167 | Cancer Center of Kansas, PA - Newton | Newton | Kansas | United States | 67114 |
168 | Menorah Medical Center | Overland Park | Kansas | United States | 66209 |
169 | Cancer Center of Kansas, PA - Parsons | Parsons | Kansas | United States | 67357 |
170 | Cancer Center of Kansas, PA - Pratt | Pratt | Kansas | United States | 67124 |
171 | Cancer Center of Kansas, PA - Salina | Salina | Kansas | United States | 67042 |
172 | Tammy Walker Cancer Center at Salina Regional Health Center | Salina | Kansas | United States | 67401 |
173 | Shawnee Mission Medical Center | Shawnee Mission | Kansas | United States | 66204 |
174 | Cotton-O'Neil Cancer Center | Topeka | Kansas | United States | 66606 |
175 | St. Francis Comprehensive Cancer Center | Topeka | Kansas | United States | 66606 |
176 | Cancer Center of Kansas, PA - Wellington | Wellington | Kansas | United States | 67152 |
177 | Associates in Womens Health, PA - North Review | Wichita | Kansas | United States | 67208 |
178 | Cancer Center of Kansas, PA - Medical Arts Tower | Wichita | Kansas | United States | 67208 |
179 | Cancer Center of Kansas, PA - Wichita | Wichita | Kansas | United States | 67214 |
180 | CCOP - Wichita | Wichita | Kansas | United States | 67214 |
181 | Via Christi Cancer Center at Via Christi Regional Medical Center | Wichita | Kansas | United States | 67214 |
182 | Wesley Medical Center | Wichita | Kansas | United States | 67214 |
183 | Cancer Center of Kansas, PA - Winfield | Winfield | Kansas | United States | 67156 |
184 | Pennington Cancer Center at Baton Rouge General | Baton Rouge | Louisiana | United States | 70806 |
185 | Mary Bird Perkins Cancer Center - Baton Rouge | Baton Rouge | Louisiana | United States | 70809 |
186 | Ochsner Health Center - Bluebonnet | Baton Rouge | Louisiana | United States | 70809 |
187 | Ochsner Health Center - Covington | Covington | Louisiana | United States | 70433 |
188 | Terrebonne General Medical Center | Houma | Louisiana | United States | 70360 |
189 | MBCCOP - LSU Health Sciences Center | New Orleans | Louisiana | United States | 70112 |
190 | Medical Center of Louisiana - New Orleans | New Orleans | Louisiana | United States | 70112 |
191 | CCOP - Ochsner | New Orleans | Louisiana | United States | 70121 |
192 | Ochsner Cancer Institute at Ochsner Clinic Foundation | New Orleans | Louisiana | United States | 70121 |
193 | Greenebaum Cancer Center at University of Maryland Medical Center | Baltimore | Maryland | United States | 21201 |
194 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | United States | 21231-2410 |
195 | Shore Regional Cancer Center at Memorial Hospital - Easton | Easton | Maryland | United States | 21601 |
196 | Union Hospital Cancer Program at Union Hospital | Elkton | Maryland | United States | 21921 |
197 | Associates in Oncology and Hematology | Kensington | Maryland | United States | 20895 |
198 | Associates in Oncology and Hematology - Medical Center Drive | Rockville | Maryland | United States | 20878 |
199 | Tufts-NEMC Cancer Center | Boston | Massachusetts | United States | 02111 |
200 | Massachusetts General Hospital | Boston | Massachusetts | United States | 02114 |
201 | Dana-Farber/Brigham and Women's Cancer Center | Boston | Massachusetts | United States | 02115 |
202 | Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute | Boston | Massachusetts | United States | 02115 |
203 | Boston University Cancer Research Center | Boston | Massachusetts | United States | 02118 |
204 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | 02215 |
205 | Caritas St. Elizabeth's Medical Center | Brighton | Massachusetts | United States | 02135-2997 |
206 | Lahey Clinic Medical Center - Burlington | Burlington | Massachusetts | United States | 01805 |
207 | Hudner Oncology Center at Saint Anne's Hospital - Fall River | Fall River | Massachusetts | United States | 02721 |
208 | Addison Gilbert Hospital | Gloucester | Massachusetts | United States | 01930 |
209 | Cape Cod Hospital | Hyannis | Massachusetts | United States | 02601 |
210 | Lowell General Hospital | Lowell | Massachusetts | United States | 01854 |
211 | Berkshire Hematology Oncology, PC | Pittsfield | Massachusetts | United States | 01201 |
212 | South Shore Hospital | South Weymouth | Massachusetts | United States | 02190 |
213 | Morton Hospital & Medical Center | Taunton | Massachusetts | United States | 02780 |
214 | Hickman Cancer Center at Bixby Medical Center | Adrian | Michigan | United States | 49221 |
215 | Saint Joseph Mercy Cancer Center | Ann Arbor | Michigan | United States | 48106-0995 |
216 | CCOP - Michigan Cancer Research Consortium | Ann Arbor | Michigan | United States | 48106 |
217 | University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | United States | 48109-0942 |
218 | Battle Creek Health System Cancer Care Center | Battle Creek | Michigan | United States | 49017 |
219 | Bay Regional Medical Center | Bay City | Michigan | United States | 48708 |
220 | Mecosta County Medical Center | Big Rapids | Michigan | United States | 49307 |
221 | Oakwood Cancer Center at Oakwood Hospital and Medical Center | Dearborn | Michigan | United States | 48123-2500 |
222 | Green Bay Oncology, Limited - Escanaba | Escanaba | Michigan | United States | 49431 |
223 | Genesys Hurley Cancer Institute | Flint | Michigan | United States | 48503 |
224 | Hurley Medical Center | Flint | Michigan | United States | 48503 |
225 | Butterworth Hospital at Spectrum Health | Grand Rapids | Michigan | United States | 49503 |
226 | CCOP - Grand Rapids | Grand Rapids | Michigan | United States | 49503 |
227 | Lacks Cancer Center at Saint Mary's Health Care | Grand Rapids | Michigan | United States | 49503 |
228 | Van Elslander Cancer Center at St. John Hospital and Medical Center | Grosse Pointe Woods | Michigan | United States | 48236 |
229 | Dickinson County Healthcare System | Iron Mountain | Michigan | United States | 49801 |
230 | Foote Memorial Hospital | Jackson | Michigan | United States | 49201 |
231 | Borgess Medical Center | Kalamazoo | Michigan | United States | 49001 |
232 | West Michigan Cancer Center | Kalamazoo | Michigan | United States | 49007-3731 |
233 | Bronson Methodist Hospital | Kalamazoo | Michigan | United States | 49007 |
234 | Haematology-Oncology Associates of Ohio and Michigan, PC | Lambertville | Michigan | United States | 48144 |
235 | Sparrow Regional Cancer Center | Lansing | Michigan | United States | 48912-1811 |
236 | St. Mary Mercy Hospital | Livonia | Michigan | United States | 48154 |
237 | Community Cancer Center of Monroe | Monroe | Michigan | United States | 48162 |
238 | Mercy Memorial Hospital - Monroe | Monroe | Michigan | United States | 48162 |
239 | Mercy General Health Partners | Muskegon | Michigan | United States | 49443 |
240 | St. Joseph Mercy Oakland | Pontiac | Michigan | United States | 48341-2985 |
241 | Mercy Regional Cancer Center at Mercy Hospital | Port Huron | Michigan | United States | 48060 |
242 | William Beaumont Hospital - Royal Oak Campus | Royal Oak | Michigan | United States | 48073 |
243 | Seton Cancer Institute at Saint Mary's - Saginaw | Saginaw | Michigan | United States | 48601 |
244 | Lakeland Regional Cancer Care Center - St. Joseph | Saint Joseph | Michigan | United States | 49085 |
245 | Oncology Care Associates, PLLC | Saint Joseph | Michigan | United States | 49085 |
246 | Munson Medical Center | Traverse City | Michigan | United States | 49684 |
247 | St. John Macomb Hospital | Warren | Michigan | United States | 48093 |
248 | Metro Health Hospital | Wyoming | Michigan | United States | 49519 |
249 | Alexandria | Minnesota | United States | 56308 | |
250 | Fairview Ridges Hospital | Burnsville | Minnesota | United States | 55337 |
251 | Mercy and Unity Cancer Center at Mercy Hospital | Coon Rapids | Minnesota | United States | 55433 |
252 | Duluth Clinic Cancer Center - Duluth | Duluth | Minnesota | United States | 55805-1983 |
253 | CCOP - Duluth | Duluth | Minnesota | United States | 55805 |
254 | Miller - Dwan Medical Center | Duluth | Minnesota | United States | 55805 |
255 | Fairview Southdale Hospital | Edina | Minnesota | United States | 55435 |
256 | Fergus Falls | Minnesota | United States | 56537 | |
257 | Mercy and Unity Cancer Center at Unity Hospital | Fridley | Minnesota | United States | 55432 |
258 | Hutchinson Area Health Care | Hutchinson | Minnesota | United States | 55350 |
259 | Meeker County Memorial Hospital | Litchfield | Minnesota | United States | 55355 |
260 | HealthEast Cancer Care at St. John's Hospital | Maplewood | Minnesota | United States | 55109 |
261 | Minnesota Oncology Hematology, PA - Maplewood | Maplewood | Minnesota | United States | 55109 |
262 | Virginia Piper Cancer Institute at Abbott - Northwestern Hospital | Minneapolis | Minnesota | United States | 55407 |
263 | Hennepin County Medical Center - Minneapolis | Minneapolis | Minnesota | United States | 55415 |
264 | Masonic Cancer Center at University of Minnesota | Minneapolis | Minnesota | United States | 55455 |
265 | Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center | Robbinsdale | Minnesota | United States | 55422-2900 |
266 | Mayo Clinic Cancer Center | Rochester | Minnesota | United States | 55905 |
267 | CentraCare Clinic - River Campus | Saint Cloud | Minnesota | United States | 56303 |
268 | Coborn Cancer Center | Saint Cloud | Minnesota | United States | 56303 |
269 | CCOP - Metro-Minnesota | Saint Louis Park | Minnesota | United States | 55416 |
270 | Park Nicollet Cancer Center | Saint Louis Park | Minnesota | United States | 55416 |
271 | Regions Hospital Cancer Care Center | Saint Paul | Minnesota | United States | 55101 |
272 | HealthEast Cancer Care at St. Joseph's Hospital | Saint Paul | Minnesota | United States | 55102 |
273 | United Hospital | Saint Paul | Minnesota | United States | 55102 |
274 | St. Francis Cancer Center at St. Francis Medical Center | Shakopee | Minnesota | United States | 55379 |
275 | Ridgeview Medical Center | Waconia | Minnesota | United States | 55387 |
276 | Willmar Cancer Center at Rice Memorial Hospital | Willmar | Minnesota | United States | 56201 |
277 | HealthEast Cancer Care at Woodwinds Health Campus | Woodbury | Minnesota | United States | 55125 |
278 | Minnesota Oncology Hematology, PA - Woodbury | Woodbury | Minnesota | United States | 55125 |
279 | Hattiesburg Clinic, PA at Forrest General | Hattiesburg | Mississippi | United States | 39401 |
280 | Hematology & Oncology Clinic | Hattiesburg | Mississippi | United States | 39402 |
281 | Regional Cancer Center at Singing River Hospital | Pascagoula | Mississippi | United States | 39581 |
282 | Ellis Fischel Cancer Center at University of Missouri - Columbia | Columbia | Missouri | United States | 65203 |
283 | Independence Regional Health Center | Independence | Missouri | United States | 64050 |
284 | Truman Medical Center - Hospital Hill | Kansas City | Missouri | United States | 64108 |
285 | Saint Luke's Cancer Institute at Saint Luke's Hospital | Kansas City | Missouri | United States | 64111 |
286 | St. Joseph Medical Center | Kansas City | Missouri | United States | 64114 |
287 | North Kansas City Hospital | Kansas City | Missouri | United States | 64116 |
288 | Parvin Radiation Oncology | Kansas City | Missouri | United States | 64116 |
289 | CCOP - Kansas City | Kansas City | Missouri | United States | 64131 |
290 | Research Medical Center | Kansas City | Missouri | United States | 64132 |
291 | Liberty Hospital | Liberty | Missouri | United States | 64068 |
292 | Heartland Regional Medical Center | Saint Joseph | Missouri | United States | 64506 |
293 | Missouri Baptist Cancer Center | Saint Louis | Missouri | United States | 63131 |
294 | Christian Hospital Northeast Cancer Care Center | Saint Louis | Missouri | United States | 63136 |
295 | Arch Medical Services, Incorporated at Center for Cancer Care and Research | Saint Louis | Missouri | United States | 63141 |
296 | CCOP - Cancer Research for the Ozarks | Springfield | Missouri | United States | 65802 |
297 | St. John's Regional Health Center | Springfield | Missouri | United States | 65804 |
298 | Hulston Cancer Center at Cox Medical Center South | Springfield | Missouri | United States | 65807 |
299 | CCOP - Montana Cancer Consortium | Billings | Montana | United States | 59101 |
300 | Hematology-Oncology Centers of the Northern Rockies - Billings | Billings | Montana | United States | 59101 |
301 | Northern Rockies Radiation Oncology Center | Billings | Montana | United States | 59101 |
302 | St. Vincent Healthcare Cancer Care Services | Billings | Montana | United States | 59101 |
303 | Billings Clinic - Downtown | Billings | Montana | United States | 59107-7000 |
304 | St. James Healthcare Cancer Care | Butte | Montana | United States | 59701 |
305 | Big Sky Oncology | Great Falls | Montana | United States | 59405-5309 |
306 | Great Falls Clinic - Main Facility | Great Falls | Montana | United States | 59405 |
307 | Sletten Cancer Institute at Benefis Healthcare | Great Falls | Montana | United States | 59405 |
308 | Great Falls | Montana | United States | 59405 | |
309 | Northern Montana Hospital | Havre | Montana | United States | 59501 |
310 | Glacier Oncology, PLLC | Kalispell | Montana | United States | 59901 |
311 | Kalispell Medical Oncology at KRMC | Kalispell | Montana | United States | 59901 |
312 | Kalispell Regional Medical Center | Kalispell | Montana | United States | 59901 |
313 | Community Medical Center | Missoula | Montana | United States | 59801 |
314 | Guardian Oncology and Center for Wellness | Missoula | Montana | United States | 59804 |
315 | Montana Cancer Specialists at Montana Cancer Center | Missoula | Montana | United States | 59807-7877 |
316 | Montana Cancer Center at St. Patrick Hospital and Health Sciences Center | Missoula | Montana | United States | 59807 |
317 | Good Samaritan Cancer Center at Good Samaritan Hospital | Kearney | Nebraska | United States | 68848-1990 |
318 | Cancer Resource Center - Lincoln | Lincoln | Nebraska | United States | 68510 |
319 | CCOP - Missouri Valley Cancer Consortium | Omaha | Nebraska | United States | 68106 |
320 | Methodist Estabrook Cancer Center | Omaha | Nebraska | United States | 68114 |
321 | Immanuel Medical Center | Omaha | Nebraska | United States | 68122 |
322 | Alegant Health Cancer Center at Bergan Mercy Medical Center | Omaha | Nebraska | United States | 68124 |
323 | Creighton University Medical Center | Omaha | Nebraska | United States | 68131-2197 |
324 | University Medical Center of Southern Nevada | Las Vegas | Nevada | United States | 89102 |
325 | CCOP - Nevada Cancer Research Foundation | Las Vegas | Nevada | United States | 89106 |
326 | Elliot Regional Cancer Center at Elliot Hospital | Manchester | New Hampshire | United States | 03103 |
327 | John F. Kennedy Medical Center | Edison | New Jersey | United States | 08818 |
328 | CentraState Medical Center | Freehold | New Jersey | United States | 07728 |
329 | St. Barnabas Medical Center Cancer Center | Livingston | New Jersey | United States | 07039 |
330 | Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton | Marlton | New Jersey | United States | 08053 |
331 | Carol G. Simon Cancer Center at Morristown Memorial Hospital | Morristown | New Jersey | United States | 07962 |
332 | Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School | New Brunswick | New Jersey | United States | 08903 |
333 | Overlook Hospital | Summit | New Jersey | United States | 07902 |
334 | Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare | Vineland | New Jersey | United States | 08360 |
335 | Cancer Institute of New Jersey at Cooper - Voorhees | Voorhees | New Jersey | United States | 08043 |
336 | Fox Chase Virtua Health Cancer Program at Virtua West Jersey | Voorhees | New Jersey | United States | 08043 |
337 | Our Lady of Mercy Medical Center Comprehensive Cancer Center | Bronx | New York | United States | 10466 |
338 | Kings County Hospital Center | Brooklyn | New York | United States | 11203 |
339 | SUNY Downstate Medical Center | Brooklyn | New York | United States | 11203 |
340 | Veterans Affairs Medical Center - Buffalo | Buffalo | New York | United States | 14215 |
341 | CCOP - Hematology-Oncology Associates of Central New York | East Syracuse | New York | United States | 13057 |
342 | Ralph Lauren Center for Cancer Care and Prevention | New York | New York | United States | 10035 |
343 | Memorial Sloan-Kettering Cancer Center | New York | New York | United States | 10065 |
344 | James P. Wilmot Cancer Center at University of Rochester Medical Center | Rochester | New York | United States | 14642 |
345 | Nalitt Cancer Institute at Staten Island University Hospital | Staten Island | New York | United States | 10305 |
346 | SUNY Upstate Medical University Hospital | Syracuse | New York | United States | 13210 |
347 | Mission Hospitals - Memorial Campus | Asheville | North Carolina | United States | 28801 |
348 | Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | United States | 27599-7295 |
349 | Blumenthal Cancer Center at Carolinas Medical Center | Charlotte | North Carolina | United States | 28232-2861 |
350 | Presbyterian Cancer Center at Presbyterian Hospital | Charlotte | North Carolina | United States | 28233-3549 |
351 | Wayne Memorial Hospital, Incorporated | Goldsboro | North Carolina | United States | 27534 |
352 | Leo W. Jenkins Cancer Center at ECU Medical School | Greenville | North Carolina | United States | 27834 |
353 | Kinston Medical Specialists | Kinston | North Carolina | United States | 28501 |
354 | FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center | Pinehurst | North Carolina | United States | 28374 |
355 | Rutherford Hospital | Rutherfordton | North Carolina | United States | 28139 |
356 | Wake Forest University Comprehensive Cancer Center | Winston-Salem | North Carolina | United States | 27157-1096 |
357 | Bismarck Cancer Center | Bismarck | North Dakota | United States | 58501 |
358 | Medcenter One Hospital Cancer Care Center | Bismarck | North Dakota | United States | 58501 |
359 | Mid Dakota Clinic, PC | Bismarck | North Dakota | United States | 58501 |
360 | St. Alexius Medical Center Cancer Center | Bismarck | North Dakota | United States | 58502 |
361 | Dakota Cancer Institute at Dakota Clinic - South University | Fargo | North Dakota | United States | 58103 |
362 | Altru Cancer Center at Altru Hospital | Grand Forks | North Dakota | United States | 58201 |
363 | McDowell Cancer Center at Akron General Medical Center | Akron | Ohio | United States | 44307 |
364 | Summa Center for Cancer Care at Akron City Hospital | Akron | Ohio | United States | 44309-2090 |
365 | Mary Rutan Hospital | Bellefontaine | Ohio | United States | 43311 |
366 | Wood County Oncology Center | Bowling Green | Ohio | United States | 43402 |
367 | Aultman Cancer Center at Aultman Hospital | Canton | Ohio | United States | 44710-1799 |
368 | Adena Regional Medical Center | Chillicothe | Ohio | United States | 45601 |
369 | MetroHealth Cancer Care Center at MetroHealth Medical Center | Cleveland | Ohio | United States | 44109 |
370 | North Coast Cancer Care - Clyde | Clyde | Ohio | United States | 43410 |
371 | Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center | Columbus | Ohio | United States | 43210-1240 |
372 | Riverside Methodist Hospital Cancer Care | Columbus | Ohio | United States | 43214-3998 |
373 | CCOP - Columbus | Columbus | Ohio | United States | 43215 |
374 | Grant Medical Center Cancer Care | Columbus | Ohio | United States | 43215 |
375 | Mount Carmel Health - West Hospital | Columbus | Ohio | United States | 43222 |
376 | Doctors Hospital at Ohio Health | Columbus | Ohio | United States | 43228 |
377 | Grandview Hospital | Dayton | Ohio | United States | 45405 |
378 | Good Samaritan Hospital | Dayton | Ohio | United States | 45406 |
379 | Veterans Affairs Medical Center - Dayton | Dayton | Ohio | United States | 45428 |
380 | CCOP - Dayton | Dayton | Ohio | United States | 45429 |
381 | Grady Memorial Hospital | Delaware | Ohio | United States | 43015 |
382 | Hematology Oncology Center | Elyria | Ohio | United States | 44035 |
383 | Blanchard Valley Medical Associates | Findlay | Ohio | United States | 45840 |
384 | Middletown Regional Hospital | Franklin | Ohio | United States | 45005-1066 |
385 | Charles F. Kettering Memorial Hospital | Kettering | Ohio | United States | 45429 |
386 | Fairfield Medical Center | Lancaster | Ohio | United States | 43130 |
387 | St. Rita's Medical Center | Lima | Ohio | United States | 45801 |
388 | Lima Memorial Hospital | Lima | Ohio | United States | 45804 |
389 | Strecker Cancer Center at Marietta Memorial Hospital | Marietta | Ohio | United States | 45750 |
390 | Northwest Ohio Oncology Center | Maumee | Ohio | United States | 43537-1839 |
391 | St. Luke's Hospital | Maumee | Ohio | United States | 43537 |
392 | Licking Memorial Cancer Care Program at Licking Memorial Hospital | Newark | Ohio | United States | 43055 |
393 | St. Charles Mercy Hospital | Oregon | Ohio | United States | 43616 |
394 | Toledo Clinic - Oregon | Oregon | Ohio | United States | 43616 |
395 | Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford | Salem | Ohio | United States | 44460 |
396 | North Coast Cancer Care, Incorporated | Sandusky | Ohio | United States | 44870 |
397 | Mercy Medical Center | Springfield | Ohio | United States | 45504 |
398 | Community Hospital of Springfield and Clark County | Springfield | Ohio | United States | 45505 |
399 | Flower Hospital Cancer Center | Sylvania | Ohio | United States | 43560 |
400 | Mercy Hospital of Tiffin | Tiffin | Ohio | United States | 44883 |
401 | Toledo Hospital | Toledo | Ohio | United States | 43606 |
402 | St. Vincent Mercy Medical Center | Toledo | Ohio | United States | 43608 |
403 | Medical University of Ohio Cancer Center | Toledo | Ohio | United States | 43614 |
404 | CCOP - Toledo Community Hospital | Toledo | Ohio | United States | 43617 |
405 | St. Anne Mercy Hospital | Toledo | Ohio | United States | 43623 |
406 | Toledo Clinic, Incorporated - Main Clinic | Toledo | Ohio | United States | 43623 |
407 | UVMC Cancer Care Center at Upper Valley Medical Center | Troy | Ohio | United States | 45373-1300 |
408 | Fulton County Health Center | Wauseon | Ohio | United States | 43567 |
409 | Mount Carmel St. Ann's Cancer Center | Westerville | Ohio | United States | 43081 |
410 | Clinton Memorial Hospital | Wilmington | Ohio | United States | 45177 |
411 | Cancer Treatment Center | Wooster | Ohio | United States | 44691 |
412 | Ruth G. McMillan Cancer Center at Greene Memorial Hospital | Xenia | Ohio | United States | 45385 |
413 | Genesis - Good Samaritan Hospital | Zanesville | Ohio | United States | 43701 |
414 | Cleo Craig Cancer Research Clinic | Lawton | Oklahoma | United States | 73505 |
415 | Oklahoma University Cancer Institute | Oklahoma City | Oklahoma | United States | 73104 |
416 | Cancer Care Associates - Mercy Campus | Oklahoma City | Oklahoma | United States | 73120 |
417 | Kaiser Permanente Health Care - Portland | Portland | Oregon | United States | 97232 |
418 | Salem Hospital Regional Cancer Care Services | Salem | Oregon | United States | 97309-5014 |
419 | Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest | Allentown | Pennsylvania | United States | 18105 |
420 | UPMC Cancer Center at Beaver Medical Center | Beaver | Pennsylvania | United States | 15009 |
421 | St. Luke's Cancer Network at St. Luke's Hospital | Bethlehem | Pennsylvania | United States | 18015 |
422 | Bryn Mawr Hospital | Bryn Mawr | Pennsylvania | United States | 19010 |
423 | UPMC Cancer Center at Jefferson Regional Medical Center | Clairton | Pennsylvania | United States | 15025 |
424 | Geisinger Cancer Institute at Geisinger Health | Danville | Pennsylvania | United States | 17822-0001 |
425 | Oncology Hematology Associates of Northern Pennsylvania, PC at Hahne Regional Cancer Center | DuBois | Pennsylvania | United States | 15801 |
426 | Dale and Frances Hughes Cancer Center at Pocono Medical Center | East Stroudsburg | Pennsylvania | United States | 18301 |
427 | Easton Regional Cancer Center at Easton Hospital | Easton | Pennsylvania | United States | 18042 |
428 | UPMC Cancer Center - Arnold Palmer Pavilion | Greensburg | Pennsylvania | United States | 15601 |
429 | Penn State Cancer Institute at Milton S. Hershey Medical Center | Hershey | Pennsylvania | United States | 17033-0850 |
430 | UPMC Cancer Center at the John P. Murtha Pavilion | Johnstown | Pennsylvania | United States | 15901 |
431 | St. Mary Regional Cancer Center | Langhorne | Pennsylvania | United States | 19047 |
432 | Lewistown Hospital | Lewistown | Pennsylvania | United States | 17044 |
433 | Riddle Memorial Hospital Cancer Center | Media | Pennsylvania | United States | 19063 |
434 | UPMC - Moon | Moon | Pennsylvania | United States | 15108 |
435 | UPMC Cancer Center - Natrona Heights | Natrona Heights | Pennsylvania | United States | 15065 |
436 | Jameson Memorial Hospital - North Campus | New Castle | Pennsylvania | United States | 16105 |
437 | Cancer Center of Paoli Memorial Hospital | Paoli | Pennsylvania | United States | 19301-1792 |
438 | Abramson Cancer Center of the University of Pennsylvania | Philadelphia | Pennsylvania | United States | 19104-4283 |
439 | Kimmel Cancer Center at Thomas Jefferson University - Philadelphia | Philadelphia | Pennsylvania | United States | 19107-5541 |
440 | Joan Karnell Cancer Center at Pennsylvania Hospital | Philadelphia | Pennsylvania | United States | 19107 |
441 | Fox Chase Cancer Center - Philadelphia | Philadelphia | Pennsylvania | United States | 19111-2497 |
442 | Frankford Hospital Cancer Center - Torresdale Campus | Philadelphia | Pennsylvania | United States | 19114 |
443 | Albert Einstein Cancer Center | Philadelphia | Pennsylvania | United States | 19141 |
444 | UPMC - Shadyside | Pittsburgh | Pennsylvania | United States | 15213-2582 |
445 | UPMC Cancer Center at UPMC St. Margaret | Pittsburgh | Pennsylvania | United States | 15215 |
446 | Mercy Cancer Institute at Mercy Hospital | Pittsburgh | Pennsylvania | United States | 15219 |
447 | UPMC Cancer Centers | Pittsburgh | Pennsylvania | United States | 15232 |
448 | UPMC Cancer Center at UPMC Passavant | Pittsburgh | Pennsylvania | United States | 15237 |
449 | St. Clair Memorial Hospital Cancer Center | Pittsburgh | Pennsylvania | United States | 15243 |
450 | Guthrie Cancer Center at Guthrie Clinic Sayre | Sayre | Pennsylvania | United States | 18840 |
451 | Mercy Hospital Cancer Center - Scranton | Scranton | Pennsylvania | United States | 18501 |
452 | Hematology and Oncology Associates of Northeastern Pennsylvania | Scranton | Pennsylvania | United States | 18508 |
453 | Grand View Hospital | Sellersville | Pennsylvania | United States | 18960 |
454 | UPMC Cancer Center at UPMC Northwest | Seneca | Pennsylvania | United States | 16346 |
455 | Geisinger Medical Group - Scenery Park | State College | Pennsylvania | United States | 16801 |
456 | Mount Nittany Medical Center | State College | Pennsylvania | United States | 16803 |
457 | Washington Hospital Cancer Center | Washington | Pennsylvania | United States | 15301 |
458 | Jennersville Regional Hospital | West Grove | Pennsylvania | United States | 19390-9499 |
459 | Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center | Wilkes-Barre | Pennsylvania | United States | 18711 |
460 | CCOP - Main Line Health | Wynnewood | Pennsylvania | United States | 19096 |
461 | Lankenau Cancer Center at Lankenau Hospital | Wynnewood | Pennsylvania | United States | 19096 |
462 | Hematology and Oncology Associates of Rhode Island | Cranston | Rhode Island | United States | 02920 |
463 | Memorial Hospital of Rhode Island | Pawtucket | Rhode Island | United States | 02860 |
464 | Kent County Memorial Hospital | Warwick | Rhode Island | United States | 02886 |
465 | AnMed Cancer Center | Anderson | South Carolina | United States | 29621 |
466 | Roper St. Francis Cancer Center at Roper Hospital | Charleston | South Carolina | United States | 29401 |
467 | CCOP - Greenville | Greenville | South Carolina | United States | 29615 |
468 | CCOP - Upstate Carolina | Spartanburg | South Carolina | United States | 29303 |
469 | Gibbs Regional Cancer Center at Spartanburg Regional Medical Center | Spartanburg | South Carolina | United States | 29303 |
470 | Avera Cancer Institute | Sioux Falls | South Dakota | United States | 57105 |
471 | Medical X-Ray Center, PC | Sioux Falls | South Dakota | United States | 57105 |
472 | Sanford Cancer Center at Sanford USD Medical Center | Sioux Falls | South Dakota | United States | 57117-5039 |
473 | Blue Ridge Medical Specialists, PC | Bristol | Tennessee | United States | 37620 |
474 | Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center | Kingsport | Tennessee | United States | 37662 |
475 | Thompson Cancer Survival Center | Knoxville | Tennessee | United States | 37916 |
476 | Brooke Army Medical Center | Fort Sam Houston | Texas | United States | 78234-6200 |
477 | Wilford Hall Medical Center | Lackland Air Force Base | Texas | United States | 78236 |
478 | Doctor's Hospital of Laredo | Laredo | Texas | United States | 78041 |
479 | CCOP - Scott and White Hospital | Temple | Texas | United States | 76508 |
480 | American Fork Hospital | American Fork | Utah | United States | 84003 |
481 | Sandra L. Maxwell Cancer Center | Cedar City | Utah | United States | 84720 |
482 | Jon and Karen Huntsman Cancer Center at Intermountain Medical Center | Murray | Utah | United States | 84157 |
483 | Val and Ann Browning Cancer Center at McKay-Dee Hospital Center | Ogden | Utah | United States | 84403 |
484 | Utah Valley Regional Medical Center - Provo | Provo | Utah | United States | 84604 |
485 | Dixie Regional Medical Center - East Campus | Saint George | Utah | United States | 84770 |
486 | LDS Hospital | Salt Lake City | Utah | United States | 84103 |
487 | Utah Cancer Specialists at UCS Cancer Center | Salt Lake City | Utah | United States | 84106 |
488 | Huntsman Cancer Institute at University of Utah | Salt Lake City | Utah | United States | 84112 |
489 | Danville Regional Medical Center | Danville | Virginia | United States | 24541 |
490 | Fredericksburg Oncology, Incorporated | Fredericksburg | Virginia | United States | 22401 |
491 | Virginia Oncology Associates - Hampton | Hampton | Virginia | United States | 23666 |
492 | Lynchburg Hematology-Oncology Clinic | Lynchburg | Virginia | United States | 24501 |
493 | Southwest Virginia Regional Cancer Center at Wellmonth Health | Norton | Virginia | United States | 24273 |
494 | Virginia Commonwealth University Massey Cancer Center | Richmond | Virginia | United States | 23298-0037 |
495 | St. Joseph Cancer Center | Bellingham | Washington | United States | 98225 |
496 | Olympic Hematology and Oncology | Bremerton | Washington | United States | 98310 |
497 | Columbia Basin Hematology | Kennewick | Washington | United States | 99336 |
498 | Fred Hutchinson Cancer Research Center | Seattle | Washington | United States | 98104 |
499 | Harborview Medical Center | Seattle | Washington | United States | 98104 |
500 | Minor and James Medical, PLLC | Seattle | Washington | United States | 98104 |
501 | Group Health Central Hospital | Seattle | Washington | United States | 98112 |
502 | Swedish Cancer Institute at Swedish Medical Center - First Hill Campus | Seattle | Washington | United States | 98122-4307 |
503 | Polyclinic First Hill | Seattle | Washington | United States | 98122 |
504 | University Cancer Center at University of Washington Medical Center | Seattle | Washington | United States | 98195-6043 |
505 | Cancer Care Northwest - Spokane South | Spokane | Washington | United States | 99202 |
506 | Madigan Army Medical Center - Tacoma | Tacoma | Washington | United States | 98431 |
507 | West Virginia University Health Sciences Center - Charleston | Charleston | West Virginia | United States | 25304 |
508 | Edwards Comprehensive Cancer Center at Cabell Huntington Hospital | Huntington | West Virginia | United States | 25701 |
509 | Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital | Parkersburg | West Virginia | United States | 26102 |
510 | Princeton Community Hospital | Princeton | West Virginia | United States | 24740 |
511 | Marshfield Clinic Cancer Care at Regional Cancer Center | Eau Claire | Wisconsin | United States | 54701 |
512 | Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center | Green Bay | Wisconsin | United States | 54301-3526 |
513 | Green Bay Oncology, Limited at St. Mary's Hospital | Green Bay | Wisconsin | United States | 54303 |
514 | St. Mary's Hospital Medical Center - Green Bay | Green Bay | Wisconsin | United States | 54303 |
515 | St. Vincent Hospital Regional Cancer Center | Green Bay | Wisconsin | United States | 54307-3508 |
516 | Bay Area Cancer Care Center at Bay Area Medical Center | Marinette | Wisconsin | United States | 54143 |
517 | Marshfield Clinic - Marshfield Center | Marshfield | Wisconsin | United States | 54449 |
518 | Medical College of Wisconsin Cancer Center | Milwaukee | Wisconsin | United States | 53226 |
519 | Marshfield Clinic - Lakeland Center | Minocqua | Wisconsin | United States | 54548 |
520 | Regional Cancer Center at Oconomowoc Memorial Hospital | Oconomowoc | Wisconsin | United States | 53066 |
521 | Green Bay Oncology, Limited - Oconto Falls | Oconto Falls | Wisconsin | United States | 54154 |
522 | Ministry Medical Group at Saint Mary's Hospital | Rhinelander | Wisconsin | United States | 54501 |
523 | Marshfield Clinic - Indianhead Center | Rice Lake | Wisconsin | United States | 54868 |
524 | Green Bay Oncology, Limited - Sturgeon Bay | Sturgeon Bay | Wisconsin | United States | 54235 |
525 | Waukesha Memorial Hospital Regional Cancer Center | Waukesha | Wisconsin | United States | 53188 |
526 | Marshfield Clinic - Weston Center | Weston | Wisconsin | United States | 54476 |
527 | Marshfield Clinic - Wisconsin Rapids Center | Wisconsin Rapids | Wisconsin | United States | 54494 |
528 | Cross Cancer Institute at University of Alberta | Edmonton | Alberta | Canada | T6G 1Z2 |
529 | CancerCare Manitoba | Winnipeg | Manitoba | Canada | R3E 0V9 |
530 | Saint John Regional Hospital | Saint John | New Brunswick | Canada | E2L 4L2 |
531 | Margaret and Charles Juravinski Cancer Centre | Hamilton | Ontario | Canada | L8V 5C2 |
532 | Cancer Centre of Southeastern Ontario at Kingston General Hospital | Kingston | Ontario | Canada | K7L 5P9 |
533 | London Regional Cancer Program at London Health Sciences Centre | London | Ontario | Canada | N6A 4L6 |
534 | Ottawa Hospital Regional Cancer Centre - General Campus | Ottawa | Ontario | Canada | K1H 1C4 |
535 | Allan Blair Cancer Centre at Pasqua Hospital | Regina | Saskatchewan | Canada | S4T 7T1 |
Sponsors and Collaborators
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
Investigators
- Study Chair: Charles Fuchs, MD, MPH, Dana-Farber Cancer Institute
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- CALGB-80101
- U10CA031946
- CDR0000258787
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Arm I (5-FU/LV) | Arm II (ECF) |
---|---|---|
Arm/Group Description | Patients receive leucovorin calcium (LV) IV (20 mg/m^2 per day) and fluorouracil (5-FU) IV (425 mg/m^2 per day) on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 to 6 weeks. Patients rest for 28-35 days between course 2 and 3. | Patients receive epirubicin IV (50 mg/m^2) over 3-15 minutes and cisplatin IV (60 mg/m^2) over 1 hour on day 1 and 5-FU IV (200 mg/m^2 per day) continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses. |
Period Title: Overall Study | ||
STARTED | 280 | 266 |
COMPLETED | 280 | 266 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Arm I (5-FU/LV) | Arm II (ECF) | Total |
---|---|---|---|
Arm/Group Description | Patients receive leucovorin calcium (LV) IV (20 mg/m^2 per day) and fluorouracil (5-FU) IV (425 mg/m^2 per day) on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 to 6 weeks. Patients rest for 28-35 days between course 2 and 3. | Patients receive epirubicin IV (50 mg/m^2) over 3-15 minutes and cisplatin IV (60 mg/m^2) over 1 hour on day 1 and 5-FU IV (200 mg/m^2 per day) continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses. | Total of all reporting groups |
Overall Participants | 280 | 266 | 546 |
Age (years) [Median (Full Range) ] | |||
Median (Full Range) [years] |
59
|
58
|
58.6
|
Sex: Female, Male (Count of Participants) | |||
Female |
87
31.1%
|
88
33.1%
|
175
32.1%
|
Male |
193
68.9%
|
178
66.9%
|
371
67.9%
|
Region of Enrollment (participants) [Number] | |||
Canada |
21
7.5%
|
17
6.4%
|
38
7%
|
United States |
259
92.5%
|
249
93.6%
|
508
93%
|
Outcome Measures
Title | Overall Survival |
---|---|
Description | Overall survival is defined as the time from study enrollment to death due to any cause. The distribution of survival time will be estimated using the method of Kaplan-Meier. |
Time Frame | From study enrollment until death from any cause; up to 3 years |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Arm I (5-FU/LV) | Arm II (ECF) |
---|---|---|
Arm/Group Description | Patients receive leucovorin calcium (LV) IV (20 mg/m^2 per day) and fluorouracil (5-FU) IV (425 mg/m^2 per day) on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 to 6 weeks. Patients rest for 28-35 days between course 2 and 3. | Patients receive epirubicin IV (50 mg/m^2) over 3-15 minutes and cisplatin IV (60 mg/m^2) over 1 hour on day 1 and 5-FU IV (200 mg/m^2 per day) continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses. |
Measure Participants | 280 | 266 |
Median (95% Confidence Interval) [years] |
3.6
|
3.5
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Arm I (5-FU/LV), Arm II (ECF) |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority or Other (legacy) | |
Comments | ||
Statistical Test of Hypothesis | p-Value | |
Comments | ||
Method | ||
Comments | ||
Method of Estimation | Estimation Parameter | Cox Proportional Hazard |
Estimated Value | 0.99 | |
Confidence Interval |
(2-Sided) 95% 0.79 to 1.24 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments | Adjusted Hazard Ratio, ECF vs 5-FU/LV |
Title | Disease Free Survival |
---|---|
Description | Disease free survival is defined as the time from the date of study enrollment to death or documented second primary tumor, or cancer recurrence.The distribution of disease free survival time will be estimated using the method of Kaplan-Meier. |
Time Frame | From the date of study enrollment until death or documented second primary tumor, or cancer recurrence; up to 4 years |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Arm I (5-FU/LV) | Arm II (ECF) |
---|---|---|
Arm/Group Description | Patients receive leucovorin calcium (LV) IV (20 mg/m^2 per day) and fluorouracil (5-FU) IV (425 mg/m^2 per day) on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 to 6 weeks. Patients rest for 28-35 days between course 2 and 3. | Patients receive epirubicin IV (50 mg/m^2) over 3-15 minutes and cisplatin IV (60 mg/m^2) over 1 hour on day 1 and 5-FU IV (200 mg/m^2 per day) continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses. |
Measure Participants | 280 | 266 |
Median (95% Confidence Interval) [years] |
2.7
|
2.3
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Arm I (5-FU/LV), Arm II (ECF) |
---|---|---|
Comments | ||
Type of Statistical Test | Superiority or Other (legacy) | |
Comments | ||
Statistical Test of Hypothesis | p-Value | |
Comments | ||
Method | ||
Comments | ||
Method of Estimation | Estimation Parameter | Cox Proportional Hazard |
Estimated Value | 1.03 | |
Confidence Interval |
(2-Sided) 95% 0.83 to 1.28 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments | Adjusted Hazard Ratio, ECF vs 5-FU/LV |
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Arm I (5-FU/LV) | Arm II (ECF) | ||
Arm/Group Description | Patients receive leucovorin calcium (LV) IV (20 mg/m^2 per day) and fluorouracil (5-FU) IV (425 mg/m^2 per day) on days 1-5 of courses 1, 3, and 4. Courses repeat every 28 days. During course 2, patients undergo radiotherapy 5 days a week and receive 5-FU IV continuously for 5 to 6 weeks. Patients rest for 28-35 days between course 2 and 3. | Patients receive epirubicin IV (50 mg/m^2) over 3-15 minutes and cisplatin IV (60 mg/m^2) over 1 hour on day 1 and 5-FU IV (200 mg/m^2 per day) continuously on days 1-21 during course 1. Beginning 1 week later, patients undergo radiotherapy 5 days a week and 5-FU IV continuously for 5 weeks. Patients rest for 28-35 days before beginning course 2 of chemotherapy. Patients then receive epirubicin, cisplatin, and 5-FU as in course 1. Treatment repeats every 21 days for 2 courses. | ||
All Cause Mortality |
||||
Arm I (5-FU/LV) | Arm II (ECF) | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 11/272 (4%) | 5/251 (2%) | ||
Serious Adverse Events |
||||
Arm I (5-FU/LV) | Arm II (ECF) | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 62/272 (22.8%) | 42/251 (16.7%) | ||
Blood and lymphatic system disorders | ||||
Blood disorder | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Febrile neutropenia | 7/272 (2.6%) | 8 | 0/251 (0%) | 0 |
Hemoglobin decreased | 7/272 (2.6%) | 7 | 8/251 (3.2%) | 10 |
Hemolysis | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Transfusion: Platelets | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Cardiac disorders | ||||
Arrhythmia supraventricular | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 2 |
Atrial tachycardia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Cardiac disorder | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Edema | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Left ventricular failure | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Myocardial ischemia | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Pericardial effusion | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Sinus bradycardia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Sinus tachycardia | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 2 |
Ventricular arrhythmia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Eye disorders | ||||
Diplopia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Eye disorder | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Vision blurred | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Gastrointestinal disorders | ||||
Abdominal pain | 27/272 (9.9%) | 29 | 9/251 (3.6%) | 9 |
Ascites | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Colitis | 5/272 (1.8%) | 5 | 0/251 (0%) | 0 |
Colonic obstruction | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Constipation | 2/272 (0.7%) | 2 | 3/251 (1.2%) | 3 |
Diarrhea | 31/272 (11.4%) | 32 | 10/251 (4%) | 11 |
Dyspepsia | 2/272 (0.7%) | 2 | 4/251 (1.6%) | 4 |
Dysphagia | 6/272 (2.2%) | 6 | 1/251 (0.4%) | 1 |
Dysphagia-esophageal related to radiation | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Esophagitis | 5/272 (1.8%) | 5 | 2/251 (0.8%) | 2 |
Flatulence | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Gastrointestinal disorder | 5/272 (1.8%) | 5 | 2/251 (0.8%) | 2 |
Ileus | 0/272 (0%) | 0 | 3/251 (1.2%) | 3 |
Mucositis oral | 26/272 (9.6%) | 27 | 5/251 (2%) | 6 |
Nausea | 40/272 (14.7%) | 41 | 19/251 (7.6%) | 20 |
Rectal pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Vomiting | 22/272 (8.1%) | 24 | 15/251 (6%) | 16 |
General disorders | ||||
Chest pain | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Chills | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Death NOS | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Esophagus- Late RT Morbidity Scoring | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Fatigue | 32/272 (11.8%) | 35 | 25/251 (10%) | 28 |
Fever | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 3 |
Heart- Late RT Morbidity Scoring | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Joint- Late RT Morbidity Scoring | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Lung-Late RT Morbidity Scoring | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Mucous membrane-Late RT Morbidity Scoring | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Pain | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Infections and infestations | ||||
Catheter related infection | 2/272 (0.7%) | 2 | 4/251 (1.6%) | 4 |
Infection | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Infection with grade 3 or 4 neutropenia | 3/272 (1.1%) | 3 | 1/251 (0.4%) | 1 |
Infection without neutropenia | 4/272 (1.5%) | 4 | 1/251 (0.4%) | 1 |
Pneumonia | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Sepsis | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Injury, poisoning and procedural complications | ||||
Dermatitis radiation | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Fracture | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Wound dehiscence | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Investigations | ||||
Activated partial thromboplastin time prolonged | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Alanine aminotransferase increased | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Alkaline phosphatase increased | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Amylase increased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Aspartate aminotransferase increased | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 2 |
Blood bilirubin increased | 3/272 (1.1%) | 3 | 1/251 (0.4%) | 1 |
Creatinine increased | 7/272 (2.6%) | 7 | 3/251 (1.2%) | 3 |
INR increased | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Laboratory test abnormal | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Leukocyte count decreased | 24/272 (8.8%) | 25 | 19/251 (7.6%) | 21 |
Lymphocyte count decreased | 5/272 (1.8%) | 5 | 4/251 (1.6%) | 5 |
Neutrophil count decreased | 25/272 (9.2%) | 26 | 20/251 (8%) | 22 |
Platelet count decreased | 14/272 (5.1%) | 15 | 9/251 (3.6%) | 10 |
Serum cholesterol increased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Weight gain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Weight loss | 6/272 (2.2%) | 6 | 7/251 (2.8%) | 7 |
Metabolism and nutrition disorders | ||||
Acidosis | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Alkalosis | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Anorexia | 27/272 (9.9%) | 29 | 16/251 (6.4%) | 18 |
Blood glucose increased | 5/272 (1.8%) | 5 | 3/251 (1.2%) | 3 |
Dehydration | 16/272 (5.9%) | 16 | 9/251 (3.6%) | 10 |
Serum albumin decreased | 6/272 (2.2%) | 6 | 2/251 (0.8%) | 3 |
Serum calcium decreased | 3/272 (1.1%) | 3 | 4/251 (1.6%) | 4 |
Serum glucose decreased | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Serum magnesium decreased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Serum phosphate decreased | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Serum potassium decreased | 11/272 (4%) | 12 | 3/251 (1.2%) | 4 |
Serum sodium decreased | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Serum sodium increased | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Musculoskeletal and connective tissue disorders | ||||
Arthralgia | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Back pain | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Muscle weakness | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Musculoskeletal disorder | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Nervous system disorders | ||||
Depressed level of consciousness | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Dizziness | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Dysgeusia | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Headache | 4/272 (1.5%) | 4 | 0/251 (0%) | 0 |
Intracranial hemorrhage | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Memory impairment | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Mini mental status examination abnormal | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Neurological disorder NOS | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Peripheral motor neuropathy | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Peripheral sensory neuropathy | 6/272 (2.2%) | 6 | 4/251 (1.6%) | 4 |
Speech disorder | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Syncope | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Psychiatric disorders | ||||
Confusion | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Depression | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 3 |
Insomnia | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Renal and urinary disorders | ||||
Renal failure | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Urinary frequency | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Respiratory, thoracic and mediastinal disorders | ||||
Adult respiratory distress syndrome | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Cough | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Dyspnea | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Dyspnea (shortness of breath) | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Hiccups | 0/272 (0%) | 0 | 1/251 (0.4%) | 2 |
Hypoxia | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Pleural effusion | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Pleuritic pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Pneumonitis | 4/272 (1.5%) | 4 | 0/251 (0%) | 0 |
Respiratory disorder | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Skin and subcutaneous tissue disorders | ||||
Alopecia | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Dry skin | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Hand-and-foot syndrome | 7/272 (2.6%) | 7 | 2/251 (0.8%) | 2 |
Pruritus | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Rash desquamating | 3/272 (1.1%) | 3 | 0/251 (0%) | 0 |
Sweating | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Vascular disorders | ||||
Hemorrhage/bleeding without grade 3 or 4 thrombocytopenia | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Hypotension | 7/272 (2.6%) | 8 | 4/251 (1.6%) | 4 |
Thrombosis | 1/272 (0.4%) | 1 | 3/251 (1.2%) | 3 |
Other (Not Including Serious) Adverse Events |
||||
Arm I (5-FU/LV) | Arm II (ECF) | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 258/272 (94.9%) | 234/251 (93.2%) | ||
Blood and lymphatic system disorders | ||||
Blood disorder | 2/272 (0.7%) | 4 | 1/251 (0.4%) | 2 |
Febrile neutropenia | 10/272 (3.7%) | 11 | 8/251 (3.2%) | 10 |
Hemoglobin decreased | 80/272 (29.4%) | 165 | 81/251 (32.3%) | 180 |
Hemoglobin for leukemia studies | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Hemolysis | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Lymphatic disorder | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Thrombotic microangiopathy | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Transfusion: pRBCs | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Cardiac disorders | ||||
Arrhythmia | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Arrhythmia supraventricular | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Cardiac disorder | 0/272 (0%) | 0 | 6/251 (2.4%) | 6 |
Cardiac pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Conduction disorder | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Edema | 5/272 (1.8%) | 5 | 2/251 (0.8%) | 2 |
Myocardial ischemia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Palpitations | 1/272 (0.4%) | 2 | 0/251 (0%) | 0 |
Pericarditis | 1/272 (0.4%) | 4 | 0/251 (0%) | 0 |
Sinus bradycardia | 1/272 (0.4%) | 2 | 1/251 (0.4%) | 1 |
Sinus tachycardia | 4/272 (1.5%) | 4 | 1/251 (0.4%) | 1 |
Supraventricular tachycardia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Ventricular tachycardia | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Ear and labyrinth disorders | ||||
Ear disorder | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Ear pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 2 |
Hearing impaired | 0/272 (0%) | 0 | 3/251 (1.2%) | 3 |
Hearing test abnormal | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Middle ear inflammation | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Tinnitus | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Eye disorders | ||||
Dry eye syndrome | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Eye disorder | 3/272 (1.1%) | 6 | 2/251 (0.8%) | 3 |
Flashing vision | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Vision blurred | 2/272 (0.7%) | 3 | 1/251 (0.4%) | 1 |
Watering eyes | 2/272 (0.7%) | 3 | 2/251 (0.8%) | 2 |
Gastrointestinal disorders | ||||
Abdominal distension | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Abdominal pain | 109/272 (40.1%) | 186 | 94/251 (37.5%) | 141 |
Ascites | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Colitis | 4/272 (1.5%) | 5 | 0/251 (0%) | 0 |
Constipation | 37/272 (13.6%) | 54 | 40/251 (15.9%) | 59 |
Diarrhea | 162/272 (59.6%) | 313 | 120/251 (47.8%) | 227 |
Dry mouth | 4/272 (1.5%) | 6 | 5/251 (2%) | 6 |
Duodenal ulcer | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Dyspepsia | 18/272 (6.6%) | 24 | 21/251 (8.4%) | 35 |
Dysphagia | 24/272 (8.8%) | 29 | 23/251 (9.2%) | 37 |
Dysphagia-esophageal related to radiation | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Ear, nose and throat examination abnormal | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Enteritis | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Esophageal pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Esophageal stenosis | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Esophagitis | 11/272 (4%) | 14 | 13/251 (5.2%) | 15 |
Fistula of small intestine | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Flatulence | 10/272 (3.7%) | 13 | 4/251 (1.6%) | 9 |
Gastric hemorrhage | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Gastric stenosis | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Gastric ulcer | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Gastritis | 7/272 (2.6%) | 8 | 7/251 (2.8%) | 9 |
Gastrointestinal disorder | 8/272 (2.9%) | 9 | 7/251 (2.8%) | 8 |
Hemorrhoids | 1/272 (0.4%) | 3 | 1/251 (0.4%) | 1 |
Ileus | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 2 |
Malabsorption | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Mucositis due to radiation | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Mucositis oral | 155/272 (57%) | 248 | 107/251 (42.6%) | 168 |
Nausea | 192/272 (70.6%) | 390 | 176/251 (70.1%) | 425 |
Oral pain | 4/272 (1.5%) | 4 | 1/251 (0.4%) | 1 |
Pancreatitis | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Proctitis | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Rectal bleeding/hematochezia | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Rectal hemorrhage | 0/272 (0%) | 0 | 1/251 (0.4%) | 4 |
Salivary gland disorder | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Small intestinal obstruction | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Stomach pain | 0/272 (0%) | 0 | 3/251 (1.2%) | 4 |
Vomiting | 123/272 (45.2%) | 191 | 120/251 (47.8%) | 209 |
General disorders | ||||
Bladder- Late RT Morbidity Scoring | 0/272 (0%) | 0 | 3/251 (1.2%) | 3 |
Bone - Late RT Morbidity Scoring | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Brain- Late RT Morbidity Scoring | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Chest pain | 5/272 (1.8%) | 7 | 8/251 (3.2%) | 10 |
Chills | 3/272 (1.1%) | 5 | 3/251 (1.2%) | 4 |
Edema limbs | 3/272 (1.1%) | 3 | 7/251 (2.8%) | 10 |
Esophagus- Late RT Morbidity Scoring | 19/272 (7%) | 63 | 19/251 (7.6%) | 32 |
Facial pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Fatigue | 201/272 (73.9%) | 493 | 190/251 (75.7%) | 503 |
Fever | 10/272 (3.7%) | 11 | 6/251 (2.4%) | 6 |
Flu-like symptoms | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
General symptom | 2/272 (0.7%) | 2 | 3/251 (1.2%) | 4 |
Heart- Late RT Morbidity Scoring | 3/272 (1.1%) | 4 | 4/251 (1.6%) | 7 |
Ill-defined disorder | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Joint- Late RT Morbidity Scoring | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Kidney-Late RT Morbidity Scoring | 3/272 (1.1%) | 3 | 3/251 (1.2%) | 6 |
Larynx-Late RT Morbidity Scoring | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 2 |
Liver-Late RT Morbidity Scoring | 6/272 (2.2%) | 17 | 4/251 (1.6%) | 7 |
Localized edema | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Lung-Late RT Morbidity Scoring | 8/272 (2.9%) | 11 | 6/251 (2.4%) | 14 |
Mucous membrane-Late RT Morbidity Scoring | 3/272 (1.1%) | 3 | 4/251 (1.6%) | 5 |
Pain | 19/272 (7%) | 31 | 23/251 (9.2%) | 32 |
Pericardial pain | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Radiation-Other(Specify,_____) | 17/272 (6.3%) | 24 | 11/251 (4.4%) | 28 |
Salivary glands-Late RT Morbidity Scoring | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Skin-Late RT Morbidity Scoring | 6/272 (2.2%) | 6 | 3/251 (1.2%) | 3 |
Small/Large intestine-Late RT Morbidity Scoring | 12/272 (4.4%) | 16 | 12/251 (4.8%) | 23 |
Subcutaneous tissue-Late RT Morbidity Scoring | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Hepatobiliary disorders | ||||
Hepatobiliary disease | 3/272 (1.1%) | 6 | 1/251 (0.4%) | 1 |
Portal hypertension | 1/272 (0.4%) | 2 | 0/251 (0%) | 0 |
Immune system disorders | ||||
Hypersensitivity | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Infections and infestations | ||||
Abdominal infection | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Bladder infection | 2/272 (0.7%) | 4 | 0/251 (0%) | 0 |
Bronchitis | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Catheter related infection | 1/272 (0.4%) | 2 | 5/251 (2%) | 6 |
Device related infection | 1/272 (0.4%) | 2 | 2/251 (0.8%) | 2 |
Esophageal infection | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Infection | 10/272 (3.7%) | 13 | 1/251 (0.4%) | 1 |
Infection with grade 3 or 4 neutropenia | 4/272 (1.5%) | 4 | 2/251 (0.8%) | 3 |
Infection with unknown ANC | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Infection without neutropenia | 6/272 (2.2%) | 6 | 7/251 (2.8%) | 7 |
Infectious colitis | 3/272 (1.1%) | 3 | 0/251 (0%) | 0 |
Opportunistic infection | 0/272 (0%) | 0 | 2/251 (0.8%) | 3 |
Paranasal sinus infection | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Penile infection | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Peripheral nerve infection | 0/272 (0%) | 0 | 2/251 (0.8%) | 3 |
Pneumonia | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Sepsis | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Sinusitis | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Skin infection | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 3 |
Stoma site infection | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Tooth infection | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Ureteritis | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Urinary tract infection | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Wound infection | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 3 |
Wound-infectious | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Injury, poisoning and procedural complications | ||||
Dermatitis radiation | 23/272 (8.5%) | 26 | 16/251 (6.4%) | 21 |
Fracture | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Intraoperative gastrointestinal injury - Appendix | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Thermal burn | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Vascular access complication | 3/272 (1.1%) | 3 | 1/251 (0.4%) | 1 |
Wound dehiscence | 0/272 (0%) | 0 | 1/251 (0.4%) | 2 |
Investigations | ||||
Activated partial thromboplastin time prolonged | 4/272 (1.5%) | 4 | 1/251 (0.4%) | 1 |
Alanine aminotransferase increased | 21/272 (7.7%) | 34 | 22/251 (8.8%) | 36 |
Alkaline phosphatase | 4/272 (1.5%) | 8 | 5/251 (2%) | 7 |
Alkaline phosphatase increased | 22/272 (8.1%) | 32 | 17/251 (6.8%) | 23 |
Amylase increased | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Aspartate aminotransferase increased | 36/272 (13.2%) | 54 | 28/251 (11.2%) | 36 |
Blood bilirubin increased | 16/272 (5.9%) | 22 | 7/251 (2.8%) | 8 |
Coagulopathy | 5/272 (1.8%) | 6 | 0/251 (0%) | 0 |
Creatine phosphokinase increased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Creatinine increased | 22/272 (8.1%) | 29 | 17/251 (6.8%) | 34 |
Gamma-glutamyltransferase increased | 2/272 (0.7%) | 4 | 2/251 (0.8%) | 4 |
Haptoglobin decreased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
INR increased | 4/272 (1.5%) | 5 | 2/251 (0.8%) | 2 |
Laboratory test abnormal | 3/272 (1.1%) | 5 | 4/251 (1.6%) | 4 |
Leukocyte count decreased | 177/272 (65.1%) | 409 | 177/251 (70.5%) | 458 |
Lipase increased | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Lymphocyte count decreased | 39/272 (14.3%) | 75 | 32/251 (12.7%) | 67 |
Neutrophil count decreased | 178/272 (65.4%) | 333 | 166/251 (66.1%) | 361 |
Platelet count decreased | 92/272 (33.8%) | 167 | 74/251 (29.5%) | 145 |
Weight gain | 0/272 (0%) | 0 | 3/251 (1.2%) | 3 |
Weight loss | 59/272 (21.7%) | 96 | 51/251 (20.3%) | 90 |
Metabolism and nutrition disorders | ||||
Acidosis | 0/272 (0%) | 0 | 1/251 (0.4%) | 2 |
Alkalosis | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Anorexia | 148/272 (54.4%) | 279 | 140/251 (55.8%) | 294 |
Blood bicarbonate decreased | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Blood glucose increased | 41/272 (15.1%) | 66 | 47/251 (18.7%) | 77 |
Dehydration | 33/272 (12.1%) | 45 | 31/251 (12.4%) | 45 |
Serum albumin decreased | 32/272 (11.8%) | 40 | 28/251 (11.2%) | 44 |
Serum calcium decreased | 28/272 (10.3%) | 38 | 23/251 (9.2%) | 28 |
Serum glucose decreased | 5/272 (1.8%) | 8 | 10/251 (4%) | 13 |
Serum magnesium decreased | 5/272 (1.8%) | 7 | 10/251 (4%) | 17 |
Serum magnesium increased | 2/272 (0.7%) | 2 | 3/251 (1.2%) | 4 |
Serum phosphate decreased | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 2 |
Serum potassium decreased | 31/272 (11.4%) | 44 | 26/251 (10.4%) | 43 |
Serum potassium increased | 7/272 (2.6%) | 8 | 4/251 (1.6%) | 4 |
Serum sodium decreased | 24/272 (8.8%) | 32 | 14/251 (5.6%) | 24 |
Serum sodium increased | 2/272 (0.7%) | 2 | 1/251 (0.4%) | 1 |
Serum triglycerides increased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Musculoskeletal and connective tissue disorders | ||||
Arthralgia | 8/272 (2.9%) | 14 | 6/251 (2.4%) | 7 |
Arthritis | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 5 |
Back pain | 7/272 (2.6%) | 12 | 11/251 (4.4%) | 14 |
Bone pain | 4/272 (1.5%) | 5 | 0/251 (0%) | 0 |
Chest wall pain | 1/272 (0.4%) | 1 | 3/251 (1.2%) | 3 |
Muscle weakness | 4/272 (1.5%) | 5 | 2/251 (0.8%) | 5 |
Muscle weakness lower limb | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Musculoskeletal disorder | 1/272 (0.4%) | 2 | 2/251 (0.8%) | 3 |
Myalgia | 7/272 (2.6%) | 8 | 4/251 (1.6%) | 7 |
Neck pain | 1/272 (0.4%) | 3 | 0/251 (0%) | 0 |
Pain in extremity | 1/272 (0.4%) | 1 | 5/251 (2%) | 7 |
Nervous system disorders | ||||
Ataxia | 2/272 (0.7%) | 2 | 2/251 (0.8%) | 2 |
Depressed level of consciousness | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Dizziness | 15/272 (5.5%) | 18 | 22/251 (8.8%) | 33 |
Dysgeusia | 27/272 (9.9%) | 41 | 20/251 (8%) | 39 |
Extrapyramidal disorder | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Headache | 13/272 (4.8%) | 17 | 17/251 (6.8%) | 23 |
Memory impairment | 0/272 (0%) | 0 | 1/251 (0.4%) | 2 |
Neuralgia | 0/272 (0%) | 0 | 2/251 (0.8%) | 4 |
Neurological disorder NOS | 2/272 (0.7%) | 4 | 0/251 (0%) | 0 |
Neuropathy - cranial | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Peripheral motor neuropathy | 2/272 (0.7%) | 2 | 5/251 (2%) | 6 |
Peripheral sensory neuropathy | 34/272 (12.5%) | 55 | 38/251 (15.1%) | 62 |
Syncope | 3/272 (1.1%) | 3 | 4/251 (1.6%) | 4 |
Syncope vasovagal | 0/272 (0%) | 0 | 3/251 (1.2%) | 3 |
Tremor | 2/272 (0.7%) | 3 | 3/251 (1.2%) | 4 |
Psychiatric disorders | ||||
Anxiety | 5/272 (1.8%) | 7 | 12/251 (4.8%) | 27 |
Depression | 9/272 (3.3%) | 13 | 18/251 (7.2%) | 29 |
Euphoria | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Insomnia | 17/272 (6.3%) | 22 | 16/251 (6.4%) | 23 |
Libido decreased | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Renal and urinary disorders | ||||
Bladder pain | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Hematuria (in the absence of vaginal bleeding) | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Hemoglobin urine positive | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 2 |
Incontinence | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Proteinuria | 0/272 (0%) | 0 | 2/251 (0.8%) | 2 |
Ureteric obstruction | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Urinary frequency | 3/272 (1.1%) | 3 | 4/251 (1.6%) | 5 |
Urinary retention | 0/272 (0%) | 0 | 1/251 (0.4%) | 3 |
Urine discoloration | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Urogenital disorder | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Reproductive system and breast disorders | ||||
Irregular menstruation | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Vaginal inflammation | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Respiratory, thoracic and mediastinal disorders | ||||
Allergic rhinitis | 4/272 (1.5%) | 7 | 2/251 (0.8%) | 3 |
Aspiration | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Bronchospasm | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Cough | 25/272 (9.2%) | 35 | 18/251 (7.2%) | 25 |
Dyspnea | 9/272 (3.3%) | 13 | 7/251 (2.8%) | 12 |
Dyspnea (shortness of breath) | 6/272 (2.2%) | 8 | 5/251 (2%) | 7 |
Epistaxis | 8/272 (2.9%) | 9 | 7/251 (2.8%) | 7 |
Hiccups | 1/272 (0.4%) | 1 | 7/251 (2.8%) | 7 |
Hypoxia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Nasal congestion | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Pharyngolaryngeal pain | 3/272 (1.1%) | 3 | 4/251 (1.6%) | 4 |
Pleural effusion | 1/272 (0.4%) | 1 | 5/251 (2%) | 6 |
Pleuritic pain | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Pneumonitis | 2/272 (0.7%) | 4 | 1/251 (0.4%) | 1 |
Respiratory disorder | 4/272 (1.5%) | 4 | 3/251 (1.2%) | 3 |
Respiratory tract hemorrhage | 2/272 (0.7%) | 3 | 0/251 (0%) | 0 |
Voice alteration | 3/272 (1.1%) | 6 | 2/251 (0.8%) | 2 |
Skin and subcutaneous tissue disorders | ||||
Alopecia | 21/272 (7.7%) | 37 | 49/251 (19.5%) | 104 |
Decubitus ulcer | 1/272 (0.4%) | 3 | 0/251 (0%) | 0 |
Dermatology | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Dry skin | 9/272 (3.3%) | 12 | 6/251 (2.4%) | 8 |
Erythema multiforme | 1/272 (0.4%) | 3 | 1/251 (0.4%) | 1 |
Hand-and-foot syndrome | 36/272 (13.2%) | 52 | 46/251 (18.3%) | 75 |
Nail disorder | 4/272 (1.5%) | 4 | 14/251 (5.6%) | 21 |
Photosensitivity | 0/272 (0%) | 0 | 1/251 (0.4%) | 1 |
Pigmentation changes (e.g., vitiligo) | 0/272 (0%) | 0 | 2/251 (0.8%) | 6 |
Pruritus | 6/272 (2.2%) | 11 | 4/251 (1.6%) | 7 |
Rash acneiform | 1/272 (0.4%) | 2 | 1/251 (0.4%) | 1 |
Rash desquamating | 30/272 (11%) | 39 | 13/251 (5.2%) | 16 |
Rash/dermatitis associated with high-dose chemotherapy or BMT studies. | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Skin disorder | 7/272 (2.6%) | 10 | 3/251 (1.2%) | 3 |
Skin hyperpigmentation | 5/272 (1.8%) | 8 | 7/251 (2.8%) | 9 |
Sweating | 2/272 (0.7%) | 2 | 6/251 (2.4%) | 7 |
Vascular disorders | ||||
Flushing | 4/272 (1.5%) | 7 | 2/251 (0.8%) | 3 |
Hemorrhage | 2/272 (0.7%) | 2 | 0/251 (0%) | 0 |
Hemorrhage/bleeding with grade 3 or 4 thrombocytopenia | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Hemorrhage/bleeding without grade 3 or 4 thrombocytopenia | 1/272 (0.4%) | 1 | 1/251 (0.4%) | 1 |
Hot flashes | 1/272 (0.4%) | 1 | 2/251 (0.8%) | 2 |
Hypertension | 0/272 (0%) | 0 | 4/251 (1.6%) | 5 |
Hypotension | 7/272 (2.6%) | 10 | 11/251 (4.4%) | 14 |
Phlebitis | 1/272 (0.4%) | 1 | 0/251 (0%) | 0 |
Thrombosis | 6/272 (2.2%) | 7 | 10/251 (4%) | 10 |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Charles S. Fuchs, MD, MPH |
---|---|
Organization | Yale Cancer Center |
Phone | (203) 785-4095 |
charles.fuchs@yale.edu |
- CALGB-80101
- U10CA031946
- CDR0000258787